ADMA Biologics, Inc. (ADMA)
15.15
+0.16
(+1.07%)
USD |
NASDAQ |
Mar 13, 16:00
15.16
+0.01
(+0.07%)
After-Hours: 20:00
ADMA Biologics Profit Margin (Quarterly) : 35.48% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | -162.1% |
| AtriCure, Inc. | 1.25% |
| Ligand Pharmaceuticals, Inc. | 75.06% |
| ACADIA Pharmaceuticals, Inc. | 96.33% |
| Savara, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 36.20% |
| Return on Assets | 26.53% |
| Return on Invested Capital | 30.11% |
| Gross Profit Margin (Quarterly) | 63.78% |
| Operating Margin (Quarterly) | 45.09% |
| Return on Net Operating Assets | 39.50% |